Midlife Empowerment and Longevity Through Optimizing Wellness

ConditionMenopause
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-65
SponsorNational University Health System, Singapore

About this trial

The goal of this observational longitudinal study is to understand how lifestyle behaviours, menopausal symptoms, and digital health data change over time in women experiencing perimenopause or menopause, and to evaluate whether a personalised digital health programme can support healthier lifestyle behaviours and improve cardiometabolic health.

The main questions it aims to answer are:

1. Can personalised lifestyle recommendations informed by wearable devices, dietary logging, and self-reported symptoms improve adherence to healthy diet, physical activity, and sleep behaviours? 2. How are menopausal symptoms associated with changes in cardiometabolic health, body composition, physical function, and quality of life over time?

Participants will:

1. Attend study visits at the National University of Singapore for health assessments, including measurements of body composition, physical function, and cardiometabolic health. 2. Wear a smartwatch or wearable device to monitor physiological and activity data throughout the study. 3. Use a mobile application to record dietary intake, menopausal symptoms, and other health-related information. 4. Receive personalised lifestyle recommendations based on their health data and engage in regular follow-up assessments over the study period.

Eligibility criteria

Qualifiers

Women aged 21-65 years old;

Report at least mild climacteric symptoms as indicated by an MRS score ≥5;

Waist circumference ≥80 cm, indicating abdominal adiposity;

Own and use a smartphone compatible with the CGM and Oura Ring.

Disqualifiers

Are currently receiving hormone replacement therapy (HRT);

Are currently using oral contraceptives;

Have been diagnosed with severe psychiatric illness requiring inpatient care;

Are concurrently enrolled in another behavioural or psychotherapy trial;

Trial design

Treatments tested in this trial

  • MELOW

Treatment groups

200 Participants
are divided into 2 treatment groups

Locations

This trial has no locations